The study employed the measurement of retinal neural layer thickness, and the histological assessment of retinal injury, by means of immunohistochemistry staining for β-amyloid plaques aggregation, TAU protein count, and IBA1, as feature signals of AD progression. The gene discussed is AIF1; the disease is Alzheimer disease.